The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES.
作者信息
Salzer Jonatan
机构信息
Department of Pharmacology and Clinical Neuroscience, Section of Neurology, Umeå University, Umeå, 90187, Sweden
出版信息
Mult Scler. 2015 Sep;21(10):1239-40. doi: 10.1177/1352458515578773. Epub 2015 Mar 31.
PMID:25828757
Abstract
摘要
相似文献
1
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES.
Mult Scler. 2015 Sep;21(10):1239-40. doi: 10.1177/1352458515578773. Epub 2015 Mar 31.
2
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NO.
Mult Scler. 2015 Sep;21(10):1240-2. doi: 10.1177/1352458515589774. Epub 2015 Aug 4.
3
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level: Commentary.多发性硬化症治疗效果的唯一确切衡量标准是脑脊液神经丝水平：评论。
Mult Scler. 2015 Sep;21(10):1242-3. doi: 10.1177/1352458515599682. Epub 2015 Aug 4.
4
Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration.神经丝轻链：一种用于神经退行性疾病的动态跨病种液相关生物标志物。
Neuron. 2016 Jul 6;91(1):1-3. doi: 10.1016/j.neuron.2016.06.030.
5
Neurofilament in clinical practice: Is the multiple sclerosis community ready?临床实践中的神经丝：多发性硬化症群体准备好了吗？
Mult Scler. 2024 May;30(6):643-645. doi: 10.1177/13524585241246536. Epub 2024 Apr 11.
6
Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity.神经丝轻链作为无疾病活动放射学征象的多发性硬化症皮质萎缩的标志物。
J Intern Med. 2021 Aug;290(2):473-476. doi: 10.1111/joim.13286. Epub 2021 Apr 19.
7
[Regulation of functions of intermediate filaments by protein phosphatases].
Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):996-1003.
8
Is CSF neurofilament light chain measurement relevant for MS?脑脊液神经丝轻链测量对多发性硬化症是否有意义？
Neurol Neuroimmunol Neuroinflamm. 2020 Sep 14;7(6). doi: 10.1212/NXI.0000000000000886. Print 2020 Nov 5.
9
New movements in neurofilament transport, turnover and disease.神经丝运输、周转及疾病方面的新进展。
Exp Cell Res. 2007 Jun 10;313(10):2110-20. doi: 10.1016/j.yexcr.2007.03.011. Epub 2007 Mar 21.
10
From neurofilament research to multiple sclerosis clinical practice: Where do we stand?从神经丝研究到多发性硬化症临床实践：我们目前的进展如何？
Neurology. 2017 Feb 28;88(9):816-817. doi: 10.1212/WNL.0000000000003676. Epub 2017 Feb 1.
引用本文的文献
1
Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study.神经丝轻链作为多发性硬化症的生物标志物：一项荟萃分析研究。
Neuropsychiatr Dis Treat. 2018 Sep 3;14:2241-2254. doi: 10.2147/NDT.S173280. eCollection 2018.
2
The cerebrospinal fluid in multiple sclerosis: far beyond the bands.多发性硬化症中的脑脊液：远不止条带现象
Einstein (Sao Paulo). 2017 Jan-Mar;15(1):100-104. doi: 10.1590/S1679-45082017RW3706.
3
Circulating immune cells in multiple sclerosis.多发性硬化症中的循环免疫细胞。
Clin Exp Immunol. 2017 Feb;187(2):193-203. doi: 10.1111/cei.12878. Epub 2016 Nov 2.
Zotero 插件